However, TGF-β signaling can also drive tumor progression by suppressing CD8+ T cells tumor infiltration (71), supporting angiogenesis (72), upregulating PD-L1 expression (73), and promoting epithelial-to-mesenchymal transition (EMT) (74). The gene discussed is CD8A; the disease is neoplasm.